Aethlon Medical, Inc. (AEMD)

Market Cap	2.37M
Revenue (ttm)	n/a
Net Income (ttm)	-13.39M
Shares Out	2.01M
EPS (ttm)	-8.58
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	144,929
Open	1.180
Previous Close	1.225
Day's Range	1.150 - 1.220
52-Week Range	1.100 - 8.440
Beta	1.69
Analysts	Buy
Price Target	28.75 (+2,336.44%)
Earnings Date	Aug 13, 2025

About AEMD

Aethlon Medical, Inc., a medical therapeutic company, focuses on developing products to treat cancer and life-threatening viral infectious, diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended for applications in cancer, and life-threatening viral infections, and use in organ transplantation. The company was founded in 1984 and is based in San Diego, California.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1984
• Employees: 9
• Stock Exchange: NASDAQ
• Ticker Symbol: AEMD
• Website: https://www.aethlonmedical.com

Analyst Summary

According to 2 analysts, the average rating for AEMD stock is "Buy." The 12-month stock price target is $28.75, which is an increase of 2,336.44% from the latest price.

Price Target

$28.75

(2,336.44% upside)

Analyst Consensus: Buy